Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Sydney: Sleep-breathing device maker ResMed plans to take global a doctor education program aimed at promoting the screening of patients seeking Ozempic-style weight loss drugs for apnea, calling ...
Resmed posts double-digit revenue and profit growth in Q2 FY26, declares dividend, and outlines plans for innovation. The Resmed CDI (ASX: RMD) share price is in focus after the company reported ...
In its Q2 2026 earnings call, ResMed Inc. reported an earnings per share (EPS) of $2.81, surpassing analysts’ forecast of $2.73 by 2.93%. The company matched revenue expectations at $1.4 billion.
SAN DIEGO (AP) — SAN DIEGO (AP) — ResMed Inc. (RMD) on Thursday reported fiscal second-quarter net income of $392.6 million. On a per-share basis, the San Diego-based company said it had net income of ...
ResMed (RMD) came out with quarterly earnings of $2.81 per share, beating the Zacks Consensus Estimate of $2.69 per share. This compares to earnings of $2.43 per share a year ago. These figures are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results